ESR1 and cancer: These findings support the idea that as PCas become androgen-insensitive, progression may be partly driven by ER-mediated pathways either in the cancer itself or through ER-mediated signaling in the stroma creating a permissive microenvironment favoring tumor progression Interrogation of the gene panel showed a prominent role of the EMT in relation to BCR.